Code I26: A Precise Tool to Strengthen VTE Surveillance
RPTH Journal (Research and Practice in Thrombosis and Haemostasis) shared an insightful post on LinkedIn:
”Current ICD codes make it difficult to track venous thrombosis incidence in real time. This original article suggests use of “I26″ which has high specificity for VTE in the Unite States, and may help capture the incidence of PE.
Authors: Jeffrey Kline, Jesse Wrenn, Alexis Drinkhorn, Mazin Alam, Steven Korzeniewski, Christopher Kabrhel”
Read the full article here.
Accurately tracking venous thromboembolism (VTE) incidence in real time remains a challenge with current ICD coding.
In the article ”Diagnostic accuracy of the international classification of disease ‘I26’ code to detect acute pulmonary embolism in a surveillance network” by Jeffrey Kline et al. published in RPTH Journal, the potential of using the ”I26” code is discussed.
This study highlights the potential of using the ICD code “I26”, which demonstrates high specificity for VTE in the United States, particularly for capturing pulmonary embolism cases.
Implementing this approach may improve surveillance and inform public health strategies!
For deeper insights and the latest research, be sure to read Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC